Dhanvantri Jeevan Rekha Fair Value
Dhanvantri Jeevan Rekha (ZDHJERK) average fair value is ₹54.47 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹19.7 (+176.52%), fair value range ₹19.84–₹182.41. See ZDHJERK book value to compare market price against book value per share.
Fair Value Analysis Export
ZDHJERK Fair Value vs Current Price — Valuation Summary
ZDHJERK average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Also explore ZDHJERK stock price history to track price trends across different timeframes.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
ZDHJERK Fair Value Analysis — Data Sources & Coverage
Dhanvantri Jeevan Rekha financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Dhanvantri Jeevan Rekha share price screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
ZDHJERK vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Dhanvantri Jeevan Rekha P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| One Global Service Provi… | ONEGLOBAL | 14.84 | 9.12 | ₹920 |
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Gujarat Kidney and Super… | GKSL | 83.28 | 3.9 | ₹1,117 |
| Invicta Diagnostic | INVICTA | 17.24 | 1.68 | ₹80 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.